A Study in CKD Patients With Type 2 Diabetes Mellitus and Albuminuria
Status:
Completed
Trial end date:
2015-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if the study drug is safe, tolerable and active in
reducing albuminuria in patients with Chronic Kidney Disease with Type 2 Diabetes.